Cédric Merlot is the CEO of Drugdesigntech which he founded in 2007.
After receiving a MSc in Chemistry, he started his career at Sanofi-Aventis in the molecular modelling group. In 2001 he joined Serono and had increasing responsibilities in the Scientific Computing department, with a focus on data management for small molecules and biologicals and computer-assisted drug design for small molecules.
He applies bioinformatics and data management expertise to support the development of the foundation Translational Platform.
As a private non-for-profit organisation, we strive to uncover the potential of existing molecules to address severe therapeutic unmet needs in rare diseases, thus giving better chances to existing drugs to reach these underserved patients.